What does Hexarelin do?

Hexarelin binds the ghrelin receptor (GHS-R1a) on your pituitary — the same receptor as ipamorelin — but with higher potency and less selectivity. It produces the largest GH pulse of any GHRP, but also significantly raises cortisol and prolactin, which counteract some of the benefits.

What makes hexarelin genuinely unique is its cardiac effects. It binds CD36 receptors on cardiac cells (independent of the GH mechanism), producing direct cardioprotective effects. This has been studied in human heart failure patients with promising preliminary results.

The main limitation is tachyphylaxis — your ghrelin receptors desensitise quickly with hexarelin, meaning the GH response diminishes substantially within 4–6 weeks of continuous use. This limits its use to short cycles.

Who uses it?

• Short-term GH pulse — when maximum GH stimulation is the goal for a limited period
• Cardiac interest — its unique CD36-mediated cardioprotective effects
• GH research — used as a provocative test for GH secretion capacity
• Rarely for long-term — tachyphylaxis and side effects make continuous use impractical

What to know before trying

Cortisol and prolactin: Unlike ipamorelin, hexarelin significantly raises both. Cortisol elevation works against the anabolic effects of GH, and prolactin elevation can suppress testosterone and libido. This is why ipamorelin has largely replaced hexarelin for longevity use.

Short cycles only: 2–4 weeks maximum, followed by extended off-periods (8+ weeks) to allow receptor resensitisation.

Cardiac research: If you’re interested in hexarelin for its cardiac effects specifically, discuss with a cardiologist. The CD36 mechanism is independent of GH release and represents a genuinely novel research direction.

Frequently Asked Questions

How it works in your body

Hexarelin activates the ghrelin receptor with high potency, triggering a strong GH pulse from the pituitary. Unlike ipamorelin, it also activates ACTH/cortisol and prolactin pathways — making it less selective. Its unique feature is CD36 receptor binding on cardiac cells, which produces direct cardioprotective effects including anti-fibrotic and anti-apoptotic actions in heart tissue — independent of the GH mechanism.

What the studies show

• GH potency: Produces the largest GH pulse of any GHRP in head-to-head comparisons
• Cardiac: Human studies in heart failure patients show improved cardiac function via CD36 pathway
• Tachyphylaxis: Well-documented receptor desensitisation within 4–6 weeks of continuous use
• Off-target effects: Significant cortisol and prolactin elevation at GH-stimulating doses

What to monitor

• IGF-1 — to confirm GH response during the short cycle
• Morning cortisol — to assess cortisol elevation
• Prolactin — important for men, as elevation can suppress testosterone
• Cardiac markers — if using for cardiac interest, discuss specific monitoring with a cardiologist

Side effects & safety

Hexarelin’s side effects are more pronounced than ipamorelin’s due to its lower selectivity:

• Cortisol elevation — significant and consistent. Counteracts the anabolic/recovery benefits of GH.
• Prolactin increase — can suppress testosterone and libido, especially with repeated use.
• Hunger stimulation — stronger than ipamorelin, from ghrelin pathway activation.
• Tachyphylaxis — GH response diminishes substantially within 4–6 weeks. The main practical limitation.
• Water retention — mild to moderate, typical of GH-elevating peptides.
• Injection site reactions — standard subcutaneous injection effects.

Who should avoid it: People seeking long-term GH optimisation (use ipamorelin instead), those sensitive to cortisol effects, men concerned about prolactin-related testosterone suppression, and anyone with active cancer.

Related